JPRN-UMIN000016630
Completed
Phase 1
The phaseI,II study of neoadjuvant chemotherapy of gemcitabine+nab-paclitaxel+S-1 for patients with locally-advanced pancreatic cancer - GAS Study I/II
Conditionslocally-advanced pancreatic cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- locally-advanced pancreatic cancer
- Sponsor
- Hiroshima University
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)severe allegy for medicine (2\)Patients with other malignant disease within 5 years (3\)Patients with active infection (4\)Patients with severe neuropathy(\>Grade2\) (5\)Patients with ileus (6\)Patients with interstitial pneumonia (7\)Patients with uncontrallable ascites or pleural fluid (8\)Patients with uncontrallable diabetes (9\)Patients with uncontrallable heart disease (10\)Patients with pregnant or possibly pregnant (14\)Patients who have judged not suitable for this study by doctor.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Phase I, II study of neoadjuvant chemotherapy with gemcitabine and nab-paclitaxel for resectable pancreatic cancerpancreatic ductal cancerJPRN-jRCTs021200003Ishido Keinosuke30
Recruiting
Phase 2
Phase II study of the neoadjuvant chemotherapy of GEM/nab-PTX for biological borderline-resectable pancreatic cancerpancreatic cancerC535836JPRN-jRCT1041230068Ebata Tomoki50
Completed
Not Applicable
PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancerHER2 positive resectable primary breast cancerJPRN-UMIN000008465Osaka Breast Cancer Chemo-Endocrine Therapy Study Group30
Completed
Phase 2
A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancerStage III gastric cancerJPRN-UMIN000001584Department of Surgery Graduate School of Medicine, Kyoto University49
Completed
Phase 2
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 in advanced esophageal cancer patients with normal oral intakeesophageal cancerJPRN-UMIN000017153Second Department of Surgery, Wakayama Medical University40